CURE-ND session at BNA 2023

Join us at BNA 2023 Festival of Neuroscience for a special parallel session convened by CURE-ND.


Will you be attending the BNA 2023 Festival of Neuroscience? Join us at a special parallel session convened by CURE-ND.

Understanding neurodegeneration through single cell- and organoid-based approaches.

  • Giles Hardingham (UK DRI at Edinburgh) Glia-neuronal interactions in Alzheimer's disease (co-chair)
  • Wei-Ting Chen (VIB - KU Leuven Center for Brain and Disease Research, Belgium) Exploiting spatial transcriptomics to understand Alzheimer's disease (co-chair)
  • Benjamin Galet (Paris Brain Institute, France) Lineage-specific molecular profiling in organoid models of Alzheimer's Disease
  • Michela Deleidi (German Centre for Neurodegenerative Diseases (DZNE), Germany) Insights on neurodegeneration from human cerebral organoids


CURE-ND, or Catalysing a United Response in Europe to Neurodegenerative Diseases, is an alliance between the German Center for Neurodegenerative Diseases (DZNE), the Paris Brain Institute (ICM), Mission Lucidity (ML) and the UK Dementia Research Institute (UK DRI).

Together these partners embrace a joint effort to accelerate the pace of scientific discovery and nurture breakthroughs in the field of neurodegenerative diseases. Besides bringing together excellent science to accelerate research and improve clinical care, CURE-ND aims to raise global awareness of the need to urgently address the challenge of neurodegenerative diseases, and to lobby for the necessary funding to be committed to research in this area. The partners are calling for a long-term vision and funding of brain research by Europe.


More UK DRI at BNA 2023
  • Join UK DRI researchers at the following BNA 2023 sessions...

    Our researchers will be presenting their work at the following:

    Sunday 23 April

    Glia in neurodegeneration: genetics, mechanisms and therapeutic targets
    12:00 – 14:40 BST
    Hazel Hall-Roberts (UK DRI at Cardiff)
    Modelling Alzheimer’s disease polygenic risk in iPSC-microglia-like cells

    Monday 24 April

    Neurovascular contributions to dementia. Session convened by The Physiological Society
    09:30 - 11:10 BST
    Axel Montagne (UK DRI at Edinburgh)
    Loss of Endothelial-Pericyte Crosstalk: A Major Driving Force in Dementia Pathology

    Developments in translational biology. Session convened by Alzheimer’s Research UK
    15:30 - 17:10 BST
    David Rubinsztein (UK DRI at Cambridge)
    Autophagy, a guardian against neurodegeneration

    Are peripheral and CNS inflammation drivers of neurodegeneration: Session convened by Parkinson's UK
    15:30 - 17:10 BST
    Soyon Hong (UK DRI at UCL)
    The gut brain hypothesis in Parkinson's disease

    Tuesday 25 April

    Vascular causes of neurodegeneration: risk factors, mechanisms, and potential treatments
    *Plenary - The Wolstencroft Lecture*
    08:30 - 09:30 BST
    Joanna Wardlaw (UK DRI at Edinburgh)

    Glial function in CNS disorders: are astrocytes the real stars?
    15:30 - 17:10 BST
    Veronique Miron (UK DRI at Edinburgh)
    Astrocyte-oligodendrocyte interaction regulates central nervous system remyelination

    Techniques/Technologies driving a better understanding of disease mechanisms: Session convened by Parkinson's UK
    15:30 - 17:10 BST
    Caleb Webber (UK DRI at Cardiff)
    Exploiting stem cell model heterogeneity with single cell RNAseq